QINECSA SOLUTIONS
LIVE

Serial Number

97753516

Owner

Qinecsa Solutions, LLC

Attorney

Zachary A. Aria

Filing Date

Jan 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

QINECSA SOLUTIONS Trademark

Serial Number: 97753516

QINECSA SOLUTIONS is a trademark filed by Qinecsa Solutions, LLC on January 13, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Qinecsa Solutions, LLC

211 Carnegie Center Drive
Princeton, NJ 08540

Entity Type: 16

Trademark Details

Filing Date

January 13, 2023

Registration Date

Not Registered

Published for Opposition

March 12, 2024

Goods & Services

Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events; Scientific and technological services, namely, scientific research and design in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; providing medical research information; medical research and product development; design and development of computer software; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research, namely, conducting clinical trials for pharmaceutical and biotechnology products; providing medical and scientific research information in the field of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; inspection of medicines; drug safety, namely, product quality testing and evaluation; Pharmaceutical drug development services; testing of medicines and vaccines; inspection of medicines and vaccines; information technology consulting services relating to installation, maintenance and repair of computer software for the pharmaceutical, biotechnology and healthcare industries; providing scientific information about the results of clinical trials; consultancy services in the fields of drug and pharmaceutical safety testing, medical and scientific research for clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance and pharmacovigilance, namely scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Software as a service (SaaS) featuring software for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; Providing on-line non-downloadable software using artificial intelligence for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; information, advisory and consultancy services relating to all the aforesaid

Outsourcing services, namely, arranging of service contracts and procurement of goods or services for others; business consultancy; business consulting, business assistance, and business management in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; database management in the field of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, and capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid

Educational services, namely, classes, seminars and training in the fields of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; conducting seminars and workshops in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; publication of books; publication of electronic books and journals on-line; providing on-line non-downloadable electronic publications, namely, books, magazines, journals, texts and documents in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid

Consultancy services in the field of regulatory compliance and regulatory compliance auditing in the pharmaceutical field

Downloadable computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; downloadable computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; downloadable computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; Downloadable computer software and downloadable computer software applications for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2026 EXRA
SOU EXTENSION 4 GRANTED
Apr 30, 2026 EX4G
SOU EXTENSION 4 FILED
Apr 30, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 30, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 28, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 28, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 28, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 7, 2025 EX2G
SOU EXTENSION 2 FILED
May 7, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 31, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 31, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 31, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 7, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Feb 1, 2024 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 19, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 11, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 12, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2023 NWOS
NEW APPLICATION ENTERED
Jan 17, 2023 NWAP